Transcend Therapeutics
Hannah Kwak has an extensive work experience in the field of clinical operations and data management. Hannah currently holds the position of Sr. Director, Clinical Operations at Transcend Therapeutics starting from May 2023. Before that, they worked at Axsome Therapeutics, Inc. where they held various roles including Director, Clinical Data Management, Associate Director, Clinical Data Management, Sr. Manager, Clinical Operations and Data Management, Senior Clinical Project Coordinator, and Clinical Project Coordinator from December 2018 to April 2023. Prior to that, Hannah worked at The EMMES Corporation as a Project Manager and Data Manager/Protocol Monitor from July 2013 to December 2018. Hannah also has experience as a Sales Associate at J.Crew, as well as a Data and Research Assistant at Johns Hopkins Bloomberg School of Public Health.
Hannah Kwak holds a B.A. in Biology from The Johns Hopkins University and a Masters of Health Sciences in Mental Health from the Johns Hopkins Bloomberg School of Public Health.
Transcend Therapeutics
1 followers
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.